Harbour Investments’s Caribou Biosciences CRBU Stock Holding History

Harbour Investments’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.24K	Buy	1,180 +180	+18%	+$309	﹤0.01%	3874
2025 Q4	$1.59K	Hold	1,000	–	–	﹤0.01%	3358
2025 Q3	$2.33K	Hold	1,000	–	–	﹤0.01%	3234
2025 Q2	$1.26K	Hold	1,000	–	–	﹤0.01%	3238
2025 Q1	$913	Hold	1,000	–	–	﹤0.01%	3258
2024 Q4	$1.59K	Hold	1,000	–	–	﹤0.01%	3062
2024 Q3	$1.96K	Hold	1,000	–	–	﹤0.01%	2928
2024 Q2	$1.64K	Hold	1,000	–	–	﹤0.01%	2864
2024 Q1	$5.14K	Hold	1,000	–	–	﹤0.01%	2472
2023 Q4	$5.73K	Hold	1,000	–	–	﹤0.01%	2361
2023 Q3	$4.78K	Buy	+1,000	New	+$6.2K	﹤0.01%	2294
2021 Q4	–	Sell	-16	Closed	–	–	2834
2021 Q3	$0	Buy	+16	New	+$391	﹤0.01%	3773

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harbour Investments's CRBU Position: Q1 2026 in Review

Harbour Investments increased its Caribou Biosciences (CRBU) stake by 18% in Q1 2026, buying an estimated $309 and bringing the position to 1,180 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #3874.

Harbour Investments first reported a position in CRBU in Q3 2021 and has held it in 12 quarters since. The position peaked at $5.73K in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

Harbour Investments held 1,180 shares of Caribou Biosciences worth $2.24K as of Q1 2026.
Harbour Investments bought 180 Caribou Biosciences shares in Q1 2026, an estimated $309.
Caribou Biosciences made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3874 holding.
Harbour Investments first reported a position in Caribou Biosciences in Q3 2021 and has held it in 12 quarters since.
Harbour Investments's Caribou Biosciences position peaked at $5.73K in Q4 2023.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.